Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marat Fudim

Showing results (411-420 of 555) with videos related to

Pageof 56
Sort By:
ESC Heart Failure|August 11, 2018
Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trialMichael Kleiner Shochat, Marat Fudim, Avraham Shotan, et al.
European Journal of Heart Failure|November 12, 2018
Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trialStephen J Greene, Gregg C Fonarow, Scott D Solomon, et al.
Journal of the American College of Cardiology|November 12, 2025
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and TreatmentMuhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, et al.
Journal of Cardiac Failure|September 19, 2024
Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events: Results From SCALE-HF 1Marat Fudim, Ugochukwu Egolum, Amir Haghighat, et al.
American Heart Journal|January 1, 2021
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis updateHusam M Salah, Subhi J Al'Aref, Muhammad Shahzeb Khan, et al.
Cardiovascular Diabetology|February 6, 2022
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysisHusam M Salah, Subhi J Al'Aref, Muhammad Shahzeb Khan, et al.
ESC Heart Failure|November 2, 2021
Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failureTarek Bekfani, Ali Hamadanchi, Shun Ijuin, et al.
European Journal of Heart Failure|May 10, 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trialsGuiomar Mendieta, Paul M Ridker, Barry A Borlaug, et al.
JACC. Advances|August 5, 2024
Feasibility of a Novel Augmented 6-Minute Incremental Step Test: A Simplified Cardiorespiratory Fitness Assessment ToolJeroen Molinger, Veraprapas Kittipibul, J Matthew Gray, et al.
ESC Heart Failure|February 19, 2026
Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysisMushood Ahmed, Eeshal Zulfiqar, Tallal Mushtaq Hashmi, et al.
Pageof 56

Showing results (411-420 of 555) with videos related to

Sort By:
Pageof 56
ESC Heart Failure|August 11, 2018
Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trialMichael Kleiner Shochat, Marat Fudim, Avraham Shotan, et al.
European Journal of Heart Failure|November 12, 2018
Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trialStephen J Greene, Gregg C Fonarow, Scott D Solomon, et al.
Journal of the American College of Cardiology|November 12, 2025
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and TreatmentMuhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, et al.
Journal of Cardiac Failure|September 19, 2024
Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events: Results From SCALE-HF 1Marat Fudim, Ugochukwu Egolum, Amir Haghighat, et al.
American Heart Journal|January 1, 2021
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis updateHusam M Salah, Subhi J Al'Aref, Muhammad Shahzeb Khan, et al.
Cardiovascular Diabetology|February 6, 2022
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysisHusam M Salah, Subhi J Al'Aref, Muhammad Shahzeb Khan, et al.
ESC Heart Failure|November 2, 2021
Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failureTarek Bekfani, Ali Hamadanchi, Shun Ijuin, et al.
European Journal of Heart Failure|May 10, 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trialsGuiomar Mendieta, Paul M Ridker, Barry A Borlaug, et al.
JACC. Advances|August 5, 2024
Feasibility of a Novel Augmented 6-Minute Incremental Step Test: A Simplified Cardiorespiratory Fitness Assessment ToolJeroen Molinger, Veraprapas Kittipibul, J Matthew Gray, et al.
ESC Heart Failure|February 19, 2026
Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysisMushood Ahmed, Eeshal Zulfiqar, Tallal Mushtaq Hashmi, et al.
Pageof 56